{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:21:37Z","timestamp":1787170897376,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.xphs.2015.12.015","type":"journal-article","created":{"date-parts":[[2016,2,27]],"date-time":"2016-02-27T19:35:55Z","timestamp":1456601755000},"page":"1043-1049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations"],"prefix":"10.1016","volume":"105","author":[{"given":"Shigeyuki","family":"Miyamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Imafuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Anraku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuna","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Otagiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2015.12.015_bib1","series-title":"All About Albumin: Biochemistry, Genetics, and Medical Applications","author":"Peters","year":"1996"},{"key":"10.1016\/j.xphs.2015.12.015_bib2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/liv.12528","article-title":"Reactive oxygen species in the vasculature: molecular and cellular mechanisms","volume":"35","author":"Garcia-Martinez","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.xphs.2015.12.015_bib3","first-page":"2617","article-title":"Albumin-drug interaction and its clinical implication","volume":"109","author":"Yamasaki","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xphs.2015.12.015_bib4","doi-asserted-by":"crossref","first-page":"e87919","DOI":"10.1371\/journal.pone.0087919","article-title":"Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin","volume":"9","author":"Sato","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2015.12.015_bib5","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bbagen.2013.04.036","article-title":"Redox properties of serum albumin","volume":"1830","author":"Anraku","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 17","key":"10.1016\/j.xphs.2015.12.015_bib6","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1681\/ASN.V12suppl_1s75","article-title":"Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure","volume":"12","author":"Mitzner","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.xphs.2015.12.015_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/MAT.0b013e3181b37d86","article-title":"Albumin dialysis MARS: knowledge from 10 years of clinical investigation","volume":"55","author":"Mitzner","year":"2009","journal-title":"ASAIO J"},{"key":"10.1016\/j.xphs.2015.12.015_bib8","article-title":"Treatment of Alzheimer disease using combination therapy with plasma exchange and haemapheresis with albumin and intravenous immunoglobulin: rationale and treatment approach of the AMBAR (Alzheimer Management By Albumin Replacement) study","author":"Boada","year":"2014","journal-title":"Neurologia"},{"key":"10.1016\/j.xphs.2015.12.015_bib9","doi-asserted-by":"crossref","first-page":"28163","DOI":"10.1074\/jbc.C112.360800","article-title":"Human serum albumin can regulate amyloid-\u03b2 peptide fiber growth in the brain interstitium: implications for Alzheimer disease","volume":"287","author":"Stanyon","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.xphs.2015.12.015_bib10","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.bpj.2013.08.025","article-title":"Mapping the interactions between the Alzheimer's A\u03b2-peptide and human serum albumin beyond domain resolution","volume":"105","author":"Algamal","year":"2013","journal-title":"Biophys J"},{"key":"10.1016\/j.xphs.2015.12.015_bib11","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3233\/JAD-131169","article-title":"In\u00a0vitro amyloid-\u03b2 binding and inhibition of amyloid-\u03b2 self-association by therapeutic albumin","volume":"38","author":"Milojevic","year":"2014","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.xphs.2015.12.015_bib12","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","article-title":"Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis","volume":"60","author":"Domenicali","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.xphs.2015.12.015_bib13","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/01.CCM.0000169876.14858.91","article-title":"Heterogeneity and oxidation status of commercial human albumin preparations in clinical use","volume":"33","author":"Bar-Or","year":"2005","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1016\/j.xphs.2015.12.015_bib14","doi-asserted-by":"crossref","first-page":"e85216","DOI":"10.1371\/journal.pone.0085216","article-title":"Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases","volume":"9","author":"Nagumo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.xphs.2015.12.015_bib15","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.xphs.2015.12.015_bib16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.xphs.2015.12.015_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.59566\/IJBS.2009.5293","article-title":"A\u00a0simple stabilization method of reduced albumin in blood and plasma for the reduced\/oxidized albumin ratio measurement","volume":"5","author":"Kubota","year":"2009","journal-title":"Int J Biomed Sci"},{"key":"10.1016\/j.xphs.2015.12.015_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbrc.2005.07.035","article-title":"The structure and function of oxidized albumin in hemodialysis patients: its role in elevated oxidative stress via neutrophil burst","volume":"334","author":"Mera","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.xphs.2015.12.015_bib19","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1002\/jps.22571","article-title":"Quantitative analysis of cysteine-34 on the anitioxidative properties of human serum albumin in hemodialysis patients","volume":"100","author":"Anraku","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2015.12.015_bib20","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/bj3490813","article-title":"Role of arg-410 and tyr-411 in human serum albumin for ligand binding and esterase-like activity","volume":"349","author":"Watanabe","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.xphs.2015.12.015_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.2042-7158.1987.tb03412.x","article-title":"A\u00a0comparative study of the interaction of warfarin with human alpha 1-acid glycoprotein and human albumin","volume":"39","author":"Otagiri","year":"1987","journal-title":"J\u00a0Pharm Pharmacol"},{"key":"10.1016\/j.xphs.2015.12.015_bib22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/iub.567","article-title":"Quantitative evaluation of the role of cysteine and methionine residues in the antioxidant activity of human serum albumin using recombinant mutants","volume":"64","author":"Iwao","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.xphs.2015.12.015_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jceh.2014.08.007","article-title":"Role of human albumin in the management of complications of liver cirrhosis","volume":"4","author":"Bernardi","year":"2014","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.xphs.2015.12.015_bib24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2014.04.012","article-title":"Human serum albumin, systemic inflammation, and cirrhosis","volume":"61","author":"Arroyo","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.xphs.2015.12.015_bib25","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.xphs.2015.12.015_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10157-012-0610-x","article-title":"A\u00a0lower level of reduced albumin induces serious cardiovascular incidence among peritoneal dialysis patients","volume":"16","author":"Terawaki","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.xphs.2015.12.015_bib27","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jhep.2014.10.031","article-title":"Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure","volume":"62","author":"Garcia-Martinez","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.xphs.2015.12.015_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/01.CCM.0000114574.18641.5D","article-title":"Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury","volume":"32","author":"Quinlan","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.xphs.2015.12.015_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1744-9987.2010.00889.x","article-title":"Decrease in reduced-form albumin among chronic kidney disease patients: new insights in cardiovascular complications","volume":"15","author":"Terawaki","year":"2011","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.xphs.2015.12.015_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12576-009-0028-8","article-title":"Human astrocytes and aortic endothelial cells actively convert the oxidized form of albumin to the reduced form: reduced albumin might participate in redox regulation of nerve and blood vessel systems","volume":"59","author":"Matsuyama","year":"2009","journal-title":"J\u00a0Physiol Sci"},{"key":"10.1016\/j.xphs.2015.12.015_bib31","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.112.045617","article-title":"Interaction between two sulfate-conjugated uremic toxins, p-cresyl sulfate and indoxyl sulfate, during binding with human serum albumin","volume":"40","author":"Watanabe","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2015.12.015_bib32","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1002\/jps.22592","article-title":"Update on the pharmacokinetics and redox properties of protein-bound uremic toxins","volume":"100","author":"Watanabe","year":"2011","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2015.12.015_bib33","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0022-3565(25)20664-4","article-title":"Mechanism of stereoselective serum binding of ketoprofen after hemodialysis","volume":"278","author":"Sakai","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2015.12.015_bib34","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1111\/j.1742-4658.2011.08316.x","article-title":"Biological characteristics of two lysines on human serum albumin in the high-affinity binding of 4Z,15Z-bilirubin-IX\u03b1 revealed by phage display","volume":"278","author":"Minomo","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.xphs.2015.12.015_bib35","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bbagen.2013.01.006","article-title":"Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatment","volume":"1830","author":"Minomo","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xphs.2015.12.015_bib36","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/labinvest.2011.71","article-title":"Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy","volume":"91","author":"Kugimiya","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.xphs.2015.12.015_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.xphs.2015.12.015_bib38","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1111\/j.1742-4658.2006.05341.x","article-title":"Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions","volume":"273","author":"Kawakami","year":"2006","journal-title":"FEBS J"},{"key":"10.1016\/j.xphs.2015.12.015_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbapap.2004.07.002","article-title":"Stabilizing mechanisms in commercial albumin preparations: octanoate and N-acetyl-L-tryptophanate protect human serum albumin against heat and oxidative stress","volume":"1702","author":"Anraku","year":"2004","journal-title":"Biochim Biophys Acta"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915002403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915002403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:13:26Z","timestamp":1748790806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915002403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0022354915002403"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2015.12.015","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Posttranslational Modification and the Functional Impairment of Human Serum Albumin in Commercial Preparations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2015.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}